SCHEMBL28528829

SCHEMBL28528829

COc1ccc(Cc2nc(N)nc(N)c2N)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.69
CYP2D6 P10635 1/20 0.69
ATM Q13315 1/20 0.69
HEXA P06865 1/20 0.54
HEXB P07686 1/20 0.54
NPSR1 Q6W5P4 1/20 0.51
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
DHFR P00374 1/20 0.48
LTA4H P09960 2/20 0.46
HTR6 P50406 1/20 0.45
IDO1 P14902 1/20 0.44
AGXT P21549 1/20 0.44
POLB P06746 1/20 0.44
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
PDE10A Q9Y233 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28391873 0.86 ALDH1A1 (0.54) ALDH1A1CYP2D6ATMNPSR1LMNA
SCHEMBL23612255 0.86 ALDH1A1 (0.82) ALDH1A1CYP2D6ATMHEXAHEXB
SCHEMBL30055740 0.86 ALDH1A1 (0.82) ALDH1A1CYP2D6ATMHEXAHEXB
SCHEMBL28585742 0.81 ALDH1A1 (0.64) ALDH1A1CYP2D6ATMNPSR1LMNA
SCHEMBL29937212 0.78 NPSR1 (0.72) ALDH1A1CYP2D6ATMHEXAHEXB
SCHEMBL28052342 0.78 DHFR (0.51) ALDH1A1CYP2D6ATMHEXAHEXB
SCHEMBL16943987 0.78 MPO (0.53) CYP2D6HEXAHEXBDHFR
SCHEMBL29558689 0.76 ALDH1A1 (0.54) ALDH1A1CYP2D6ATMNPSR1LMNA
SCHEMBL23175129 0.76 LMNA (0.70) ALDH1A1CYP2D6ATMNPSR1LMNA
SCHEMBL2325153 0.76 ALDH1A1 (0.54) ALDH1A1CYP2D6ATMHEXAHEXB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427063-A TLR7 agonists 普利缪尼治疗学股份有限公司 2022-12-02 CN disclosed
EP-4065155-A1 TLR7 AGONISTS Primmune Therapeutics, Inc. (US) 2022-10-05 EP disclosed
CN-112533607-A TLR7 agonists 普利缪尼治疗学股份有限公司 2021-03-19 CN disclosed